Oric Pharmaceuticals Files 8-K on Shareholder Vote Matters

Ticker: ORIC · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1796280

Oric Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyOric Pharmaceuticals, Inc. (ORIC)
Form Type8-K
Filed DateJun 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

TL;DR

ORIC filed an 8-K for a shareholder vote on 6/11. Details TBD.

AI Summary

Oric Pharmaceuticals, Inc. filed an 8-K on June 13, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 11, 2025. The filing does not contain specific details about the matters voted upon or any financial figures.

Why It Matters

This filing indicates that Oric Pharmaceuticals held a shareholder vote, which is a standard corporate governance event. The specific details of the vote are not disclosed in this particular filing.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure regarding a shareholder vote and does not contain information that would immediately impact the company's stock price or operations.

Key Players & Entities

  • Oric Pharmaceuticals, Inc. (company) — Registrant
  • June 11, 2025 (date) — Date of earliest event reported
  • June 13, 2025 (date) — Date of report
  • Delaware (jurisdiction) — State of incorporation
  • 240 E. Grand Ave, 2nd Floor South San Francisco, CA 94080 (address) — Principal executive offices

FAQ

What specific matters were submitted to a vote of Oric Pharmaceuticals' security holders on June 11, 2025?

The filing does not specify the exact matters submitted for a vote on June 11, 2025, only that such a submission occurred.

When did Oric Pharmaceuticals file this Form 8-K with the SEC?

Oric Pharmaceuticals filed this Form 8-K on June 13, 2025.

What is the principal executive office address for Oric Pharmaceuticals?

The principal executive office address is 240 E. Grand Ave, 2nd Floor South San Francisco, CA 94080.

What is Oric Pharmaceuticals' telephone number?

Oric Pharmaceuticals' telephone number is (650) 388-5600.

What is the SIC code for Oric Pharmaceuticals?

The Standard Industrial Classification (SIC) code for Oric Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Oric Pharmaceuticals, Inc. (ORIC).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.